FDA.reportPublic FDA data

{3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]

RxCUI
2373967
RxNorm name
{3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]
Display name
{3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]
Full name
{3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]
Term type
BPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761142Upliznainebilizumab-cdon351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
UPLIZNAINEBILIZUMABHorizon Therapeutics USA, Inc.834db232-afb0-4dcf-93e0-009ce8245c202025-12-11Warnings, Adverse reactionsExact identifier
rxcui: 2373967

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
834db232-afb0-4dcf-93e0-009ce8245c20{3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]BPCK9These highlights do not include all the information needed to use UPLIZNA ® safely and effectively. See full prescribing information for UPLIZNA ® . UPLIZNA ® (inebilizumab-cdon) injection, for intravenous use Initial U.S. Approval: 202020251211
834db232-afb0-4dcf-93e0-009ce8245c20UPLIZNA 3 Vial KitPSN9These highlights do not include all the information needed to use UPLIZNA ® safely and effectively. See full prescribing information for UPLIZNA ® . UPLIZNA ® (inebilizumab-cdon) injection, for intravenous use Initial U.S. Approval: 202020251211
834db232-afb0-4dcf-93e0-009ce8245c20Uplizna 3 Vial KitSY9These highlights do not include all the information needed to use UPLIZNA ® safely and effectively. See full prescribing information for UPLIZNA ® . UPLIZNA ® (inebilizumab-cdon) injection, for intravenous use Initial U.S. Approval: 202020251211